FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1498-1499 May 20, 1993 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rodgers, G. P. PubMed Citation

To the Editor: Rodgers et al. (Jan. 14 issue)¹ report the use of erythropoietin to induce the fetal-hemoglobin response in patients with sickle cell disease (hemoglobin S: 6 Glu-to-Val) under treatment with hydroxyurea. We report an increased level of fetal hemoglobin in a patient with hemoglobin Burke (107 Gly-to-Arg) undergoing hemodialysis who received a huge dose of erythropoietin alone.

A 66-year-old Japanese man receiving hemodialysis had severe anemia that necessitated multiple transfusions of up to 1600 ml of blood per month. Pretreatment hematologic data are shown in Table 1. An undetectable serum level of haptoglobin, an increased level . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.